Stem cell factor improvement of proliferation and maintenance of hemopoietic progenitors in myelodysplastic syndromes.

No abstract is available for this paper.

• Publication year

  1994

• Venue

  Leukemia

• Publication date

  1994-02-01

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 7508532
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Differential responses of myeloid progenitor cells from patients with myeloid leukemia and myelodysplasia to the costimulating effects of steel factor in vitro.

  1993cited by this paper
• Long-term generation and expansion of human primitive hematopoietic progenitor cells in vitro.

  1993cited by this paper
• Kit ligand improves in vitro erythropoiesis in myelodysplastic syndrome.

  1992cited by this paper
• Human recombinant stem cell factor stimulates in vitro proliferation of acute myeloid leukemia cells and expands the clonogenic cell pool.

  1992cited by this paper
• Role of c-kit ligand in the expansion of human hematopoietic progenitor cells.

  1992cited by this paper
• Effect of stem cell factor on colony growth from acquired and constitutional (Fanconi) aplastic anemia.

  1992cited by this paper
• Effect of stem cell factor on in vitro erythropoiesis in patients with bone marrow failure syndromes.

  1992cited by this paper
• In vitro marrow culture studies in the myelodysplastic syndromes.

  1992cited by this paper
• Stem cell factor stimulates the in vitro growth of bone marrow cells from aplastic anemia patients.

  1992cited by this paper
• In vitro growth and regulation of bone marrow enriched CD34+ hematopoietic progenitors in Diamond-Blackfan anemia.

  1991cited by this paper
• Mast cell growth factor, a ligand for the receptor encoded by c-kit, affects the growth in culture of the blast cells of acute myeloblastic leukemia.

  1991cited by this paper
• Expression and functional role of the proto-oncogene c-kit in acute myeloblastic leukemia cells.

  1991cited by this paper
• Effect of murine mast cell growth factor (c-kit proto-oncogene ligand) on colony formation by human marrow hematopoietic progenitor cells.

  1991cited by this paper
• Recombinant human stem cell factor synergises with GM-CSF, G-CSF, IL-3 and epo to stimulate human progenitor cells of the myeloid and erythroid lineages.

  1991cited by this paper
• Diamond-Blackfan anemia: heterogenous response of hematopoietic progenitor cells in vitro to the protein product of the steel locus.

  1991cited by this paper
• Impaired response of myelodysplastic marrow progenitors to stimulation with recombinant haemopoietic growth factors.

  1991cited by this paper
• Recombinant human stem cell factor enhances the formation of colonies by CD34+ and CD34+lin- cells, and the generation of colony-forming cell progeny from CD34+lin- cells cultured with interleukin-3, granulocyte colony-stimulating factor, or granulocyte-macrophage colony-stimulating factor.

  1991cited by this paper
• In vivo effect of human granulocyte-macrophage colony-stimulating factor on megakaryocytopoiesis.

  1991cited by this paper
• Primary structure and functional expression of rat and human stem cell factor DNAs.

  1990cited by this paper
• Identification, purification, and biological characterization of hematopoietic stem cell factor from buffalo rat liver--conditioned medium.

  1990cited by this paper
• The hematopoietic growth factor KL is encoded by the Sl locus and is the ligand of the c-kit receptor, the gene product of the W locus.

  1990cited by this paper
• Opposite effect of tumor necrosis factor alpha on granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor-dependent growth of normal and leukemic hemopoietic progenitors.

  1990cited by this paper
• Molecular cloning of mast cell growth factor, a hematopoietin that is active in both membrane bound and soluble forms.

  1990cited by this paper
• Regulatory abnormalities in the marrow of patients with myelodysplastic syndromes

  1989cited by this paper
• Clonal analysis of myelodysplastic syndromes: evidence of multipotent stem cell origin.

  1989cited by this paper
• Granulocyte-macrophage colony-stimulating factor requires interaction with accessory cells or granulocyte-colony stimulating factor for full stimulation of human myeloid progenitors.

  1989cited by this paper
• Myelodysplastic syndromes (preleukemia).

  1986cited by this paper
• The smoldering myeloid leukemic states: clinical and biologic features.

  1983cited by this paper
• Proposals for the classification of the myelodysplastic syndromes

  1982cited by this paper

• Expression of CD44 and CD35 during normal and myelodysplastic erythropoiesis.

  2015cites this paper
• Inhibition of erythropoiesis in malaria anemia: role of hemozoin and hemozoin-generated 4-hydroxynonenal.

  2010cites this paper
• Hemozoin- and 4-hydroxynonenal-mediated inhibition of erythropoiesis. Possible role in malarial dyserythropoiesis and anemia.

  2004cites this paper
• Physiopathologie des syndromes myélodysplasiques

  2002cites this paper
• [Physiopathology of myelodysplastic syndromes].

  2002cites this paper
• In vitro proliferation and differentiation of erythroid progenitors from patients with myelodysplastic syndromes : evidence for Fas-dependent apoptosis

  2002cites this paper
• Comparative analysis of the in vitro proliferation and expansion of hematopoietic progenitors from patients with aplastic anemia and myelodysplasia.

  2002cites this paper
• In vitro proliferation and differentiation of erythroid progenitors from patients with myelodysplastic syndromes: evidence for Fas-dependent apoptosis.

  2002cites this paper
• In vitro biology of the hematopoietic system in myelodysplastic syndromes.

  2001cites this paper
• Low plasma stem cell factor levels correlate with in vitro leukemic growth in myelodysplastic syndromes.

  1999cites this paper
• GCSF augments post-progenitor proliferation in serum-free cultures of myelodysplastic marrow while ATRA enhances maturation.

  1998cites this paper
• Growth characteristics of myelodysplastic CD34+ cells.

  1998cites this paper
• Harlequin granulocyte-colony stimulating factor interleukin 6 molecules with bifunctional and antagonistic activities.

  1997cites this paper
• Treatment with growth factors in myelodysplastic syndromes.

  1997cites this paper
• Response of myelodysplastic syndrome bone marrow cells to multiple cytokine stimulation in liquid cultures: an in situ hybridization study.

  1997cites this paper
• Growth factors in the therapy of myelodysplasia: biological aspects.

  1997cites this paper
• Clinical use of hematopoietic growth factors in patients with myelodysplastic syndromes.

  1997cites this paper
• Role of cytokines in leukemic type growth of myelodysplastic CD34+ cells.

  1996cites this paper
• Proliferation and differentiation of myelodysplastic CD34+ cells.

  1996cites this paper
• The effects of human FLT3 ligand on in vitro human megakaryocytopoiesis.

  1996cites this paper
• Peripheral blood stem cells in acute myeloid leukemia: biology and clinical applications.

  1996cites this paper
• Response of myelodysplastic syndrome marrow progenitor cells to stimulation with cytokine combinations in a stroma‐free long‐term culture system

  1996cites this paper
• Erythropoiesis in myelodysplastic syndrome: expression of receptors for erythropoietin and kit ligand.

  1996cites this paper
• Biologic and clinical implications of marrow culture studies in the myelodysplastic syndromes.

  1996cites this paper
• Role of cytokines in leukemic type growth of myelodysplastic CD34+ cells

  1996cites this paper
• Responsiveness to stem cell factor (SCF) of peripheral blood colony-forming cells from patients with myelodysplastic syndromes (MDS).

  1995cites this paper
• The problem of thrombocytopenia and its management

  1995cites this paper
• Hemoglobin F synthesis is not restricted to fetal erythropoietic organs during extramedullary hematopoiesis.

  1994cites this paper
• Generation of anti‐tumour activity by OKT3‐stimulation in multiple myeloma: in vitro inhibition of autologous haemopoiesis

  1994cites this paper